Coccidiosis in Calves: Clinical Impact and Modern Control Measures
Introduction
Bovine coccidiosis is a parasitic enteric disease of young cattle caused by apicomplexan protozoa of the genus Eimeria. Global systematic reviews indicate that Eimeria spp. are among the most prevalent enteropathogens in pre-weaned and weaned calves, with infection rates exceeding 80% in many intensive rearing systems [1, 2]. Clinical disease arises primarily from infection with Eimeria bovis and Eimeria zuernii, although other species such as E. alabamensis and E. auburnensis contribute to subclinical production losses [3, 4]. The economic impact stems not only from mortality and morbidity but also from reduced growth rates, increased susceptibility to secondary infections, and costs associated with treatment and prevention.
This article provides an exhaustive examination of the clinical impact of coccidiosis in calves and evaluates modern control measures, including advances in diagnostics, anticoccidial pharmacotherapy, and management strategies.
Pathogenesis and Clinical Impact
Lifecycle and Host Cell Interactions
Eimeria species have a direct lifecycle confined to the intestinal epithelium. After ingestion of sporulated oocysts, sporozoites are released in the small intestine and invade enterocytes, initiating merogony (asexual reproduction). E. bovis primarily parasitizes the lower small intestine and cecum, whereas E. zuernii targets the colon and cecum. Merogony results in the destruction of infected cells, leading to villous atrophy, crypt hyperplasia, and mucosal inflammation [1, 3]. The prepatent period for E. bovis is approximately 18-21 days; for E. zuernii, it is 16-19 days [2]. Oocyst shedding begins during the patent period and can persist for several weeks, with peak excretion occurring 2-3 weeks after initial infection.
Oocyst Shedding Patterns and Disease Severity
Oocyst shedding is intermittent and influenced by host immunity, age, and concurrent infections. Calves become infected shortly after birth due to environmental contamination. Subclinical infections are common, but precipitating factors such as stress from weaning, transportation, overcrowding, and dietary changes can trigger clinical outbreaks [5, 4]. Clinical signs include profuse watery diarrhea, tenesmus, dehydration, anemia, and in severe cases, dysentery and rectal prolapse. A retrospective study in Argentina reported that coccidiosis accounted for 20-30% of diarrheic episodes in calves under six months of age [4].
Coinfections with other pathogens, such as Cryptosporidium parvum and bovine coronavirus, exacerbate clinical severity [5, 2]. Varegg et al. demonstrated that calves co-infected with C. parvum and bovine coronavirus exhibited prolonged oocyst shedding and more severe diarrhea compared to mono-infections [5]. Similarly, Kabir et al. identified Cryptosporidium and Eimeria as common etiological agents of calf diarrhea in Japan, highlighting the importance of differential diagnosis [2].
Diagnostic Approaches
Fecal Flotation and Oocyst Quantification
Standard diagnosis relies on detection and enumeration of oocysts in feces using flotation methods (e.g., Sheather's sugar solution or saturated sodium nitrate). Sensitivity is enhanced by centrifugal flotation. Oocysts are identified by size, shape, and morphological features; E. bovis oocysts are ovoid (23-32 × 18-24 μm) with a micropyle, while E. zuernii are spherical to subspherical (16-20 μm in diameter) [1]. Quantitative counts >5000 oocysts per gram of feces are considered indicative of clinical coccidiosis, though subclinical shedding can be lower.
Molecular Diagnostics
Species-specific PCR and quantitative real-time PCR assays allow precise identification of Eimeria species, differentiation from Cryptosporidium, and estimation of infection intensity [3, 2]. Arsenopoulos et al. used molecular methods to survey weaned dairy calves in Greece, revealing that E. bovis and E. zuernii were the predominant species, with coinfection rates correlating with management risk factors such as poor hygiene and group housing [3]. Deep learning-based tools have also been developed for automated detection of Cryptosporidium oocysts, a methodology that can be adapted for Eimeria oocyst enumeration in epizootiological surveys [6].
Differential Diagnosis
Diarrhea in calves has multiple causes, including bacterial (e.g., Salmonella enterica serovar Typhimurium, as discussed in the article Salmonella enterica Serovar Typhimurium in Backyard Poultry Flocks), viral (e.g., bovine coronavirus), and parasitic (e.g., Cryptosporidium parvum). The clinical model for cryptosporidiosis described by Riggs and Schaefer provides a framework for evaluating therapeutic efficacy that is also applicable to Eimeria [7].
Table 1: Key Eimeria Species in Calves
| Species | Pathogenicity | Primary Site | Prepatent Period | Oocyst Size (μm) |
|---|---|---|---|---|
| E. bovis | High | Lower small intestine, cecum | 18-21 days | 23-32 × 18-24 |
| E. zuernii | High | Colon, cecum | 16-19 days | 16-20 (spherical) |
| E. alabamensis | Moderate | Small intestine | 9-12 days | 18-21 × 14-16 |
| E. auburnensis | Low | Small intestine | 17-19 days | 30-42 × 20-26 |
Modern Control Measures
Anticoccidial Drugs
Two major classes of anticoccidial compounds are used in calves: ionophore antibiotics (e.g., monensin, lasalocid) and triazine derivatives (e.g., toltrazuril, ponazuril). Ionophores disrupt mitochondrial ion gradients in sporozoites and merozoites, impairing energy metabolism. Toltrazuril inhibits pyrimidine synthesis in the parasite, affecting all intracellular stages. Both agents are administered either as feed additives (ionophores) or as a single oral dose (toltrazuril) at the onset of clinical signs. Metaphylactic use during high-risk periods (e.g., 7 days before weaning) reduces oocyst shedding and clinical disease [1, 4].
Table 2: Anticoccidial Agents Used in Calves
| Agent | Class | Mechanism | Route | Dose |
|---|---|---|---|---|
| Monensin | Ionophore | Disrupts Na+/K+ gradient | Feed additive | 100-200 g/tonne |
| Lasalocid | Ionophore | Same as monensin | Feed additive | 100-150 g/tonne |
| Toltrazuril | Triazine | Inhibits dihydroorotate dehydrogenase | Oral (single dose) | 15-20 mg/kg |
| Ponazuril | Triazine | Same as toltrazuril | Oral (single dose) | 5 mg/kg |
The emergence of resistance to ionophores has been documented in poultry but remains less characterized in cattle. Rotational use of anticoccidials and integration with management practices is recommended to delay resistance [8].
Management Strategies
Hygiene and environmental management are critical. Oocysts are highly resistant to environmental conditions and many disinfectants; thorough cleaning and drying of pens, removal of manure, and use of high-pressure steam are effective. All-in/all-out management with disinfection between groups reduces pathogen load. Calves should be housed in small, clean groups to minimize ingestion of sporulated oocysts. Adequate colostrum intake and nutritional management (e.g., balanced fiber intake) support immune development [3, 8].
Genetic Resistance
Host genetics influence susceptibility to coccidiosis. Toral et al. demonstrated that coinfection affects phenotypic but not genetic resistance to common parasites, suggesting that breeding programs selecting for general parasite resistance could reduce Eimeria burden without compromising resilience [8]. However, such approaches require validation in diverse production systems.
Alternative and Phytochemical Therapies
Research into natural compounds is ongoing. De Siqueira et al. reported that papaya (Carica papaya) latex and purified papain exhibit in vitro activity against E. bovis oocysts, disrupting the oocyst wall and reducing sporulation [9]. Although field efficacy remains to be confirmed, phytochemicals offer potential for integrated control with reduced chemical residues.
Diagnostic and Control Algorithm
The following decision tree outlines a recommended workflow for managing suspected coccidiosis in calves.
flowchart TD
A[Calves with diarrhea], > B[Collect fresh fecal sample]
B, > C[Perform quantitative fecal flotation]
C, > D{>5000 oocysts per gram?}
D, >|Yes| E[Confirm Eimeria spp. identification]
D, >|No| F[Consider other etiologies: Cryptosporidium, viruses, bacteria]
E, > G{Species identified?}
G, >|E. bovis or E. zuernii| H[Initiate anticoccidial treatment]
H, > I[Metaphylaxis for group if high risk]
I, > J[Implement hygiene and management measures]
J, > K[Monitor oocyst shedding after 2 weeks]
K, > L{Reduction in shedding?}
L, >|Yes| M[Continue management]
L, >|No| N[Investigate drug resistance or reinfection]
N, > O[Adjust control strategy]
F, > P[Perform molecular panel for co-infections]
P, > Q[Differential treatment]
Conclusions and Future Directions
Coccidiosis remains a major constraint to calf health and productivity in intensive livestock systems. The predominance of E. bovis and E. zuernii necessitates species-level diagnostics to guide therapy. Modern control requires an integrated approach combining targeted anticoccidial use, rigorous hygiene, and supportive management. Advances in molecular diagnostics, including deep learning-based oocyst detection [6] and multiplex PCR panels, enable rapid and accurate diagnosis. Coinfections with Cryptosporidium spp. and Giardia duodenalis are common and must be ruled out using combined diagnostic techniques [10, 11, 12]. The zoonotic potential of Cryptosporidium and Giardia further underscores the need for effective on-farm control [10, 11, 12].
Future research should focus on developing anticoccidial vaccines for cattle (currently unavailable), understanding the genetic basis of resistance [8], and evaluating sustainable alternatives such as phytochemicals [9]. Integrated epidemiological and molecular analyses, as exemplified by studies in Greece [3], Japan [2], and Argentina [4], provide essential data for risk factor identification and intervention design.
References
[1] Shamsi L, Pouryousef A, Mohammadi MR, et al. Eimeria spp. in Cattle: A Global Systematic Review and Meta-Analysis. Vet Med Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42113544/
[2] Kabir MHB, Murakoshi F, Fukuda Y, et al. Identification of Cryptosporidium and Eimeria associated with diarrhea in calves in Japan (2020-2022). Parasitol Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41667631/
[3] Arsenopoulos KV, Chrysanthopoulos S, Papadopoulos E. Molecular Investigation of Eimeria spp. Infection in Weaned Dairy Calves in Thessaly, Greece, and Associated Risk Factors. Int J Mol Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41898762/
[4] Vilatuña EJ, Cantón G, Ovelar MF, et al. Bovine coccidiosis: Retrospective study in Central Argentina. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651633/
[5] Varegg MS, Stokstad M, Bartley PM, et al. Cryptosporidium parvum and bovine coronavirus in naturally and experimentally exposed calves: clinical outcome and pathogen shedding. Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41933416/
[6] Şahinduran Ş, Kırbaş İ, Çifci A. A deep learning-based tool for rapid and automated detection of Cryptosporidium oocysts: A new approach for veterinary diagnostics and epizootiological surveys. Exp Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41529739/
[7] Riggs MW, Schaefer DA. Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics. Methods Mol Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41144210/
[8] Toral FLB, Souza MV, de Moraes MM, et al. Coinfection affects the phenotypic but not genetic resistance of cattle to common parasites. Genet Sel Evol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41057794/
[9] de Siqueira LN, de Souza DCT, Mamani RCC, et al. In Vitro Action of Papaya (Carica Papaya) Latex and Pure Papain Against Eimeria Bovis Oocysts. Acta Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41100022/
[10] Yu Q, Chen S, Zhang X, et al. Genetic Characterization and Zoonotic Potential of Cryptosporidium spp. and Giardia duodenalis in Cattle From Northeast China. Transbound Emerg Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/42169685/
[11] Gareh A, Elbarbary NK, Abd El-Halim MO, et al. Cryptosporidiosis at the human-ruminant interface in Aswan, Egypt: a one health epidemiological study using microscopy, immunofluorescence, and PCR. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42152050/
[12] Louro M, Linhares JCT, Pinto CA, et al. Integrated epidemiological and molecular analysis of Cryptosporidium spp. and Giardia duodenalis isolates in dairy calves from Terceira Island, Azores. Parasitol Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41350959/
[13] Somelar E, Carnovale F, da Silva JFM, et al. Seroprevalence of Neospora caninum in dairy cattle of Terceira Island in association with their reproductive efficiency. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819952/
[14] Renfer H, Frey CF, Studer E, et al. [Seroprevalence of Neospora caninum in Hérens cows in the canton Valais - A prospective, representative field study]. Schweiz Arch Tierheilkd. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41185564/
[15] Sonzogni-Desautels K, Chen JF, Mead JR, et al. Mouse Models for Use in Cryptosporidium Infection Studies, Quantification of Parasite Burden Using Flow Cytometry, qPCR and Histopathology, and Confocal Imaging of Oocysts. Methods Mol Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41144209/